Soren Germer, PhD, leads the sequencing and analytics teams at the New York Genome Center (NYGC), overseeing sequencing production, sequencing analytics, methods development, clinical sequencing and analytics, project management, software engineering, and computational biology. He was appointed to this position in January 2019.
Dr. Germer joined NYGC in March of 2012 as a Sequencing Program Manager and was involved in establishing operations at NYGC at multiple levels, most recently serving as Senior Scientific Director, Sequencing Operations. Prior to NYGC, he was a translational research scientist at Roche Pharmaceuticals, where he led next-generation sequencing lab supporting pre-clinical and early development programs in the areas of virology, oncology, immunology and metabolic diseases. He began his career at Roche Molecular Diagnostics, where he focused on developing new techniques for SNP genotyping and applying them to complex disease research.
Dr. Germer attended the University of Copenhagen, and received his PhD from the University of California at Berkeley.